Exane Derivatives’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-28
| Closed | -$19 | – | 974 |
|
|
2020
Q4 | $19 | Hold |
28
| – | – | ﹤0.01% | 806 |
|
|
2020
Q3 | $63 | Hold |
28
| – | – | ﹤0.01% | 707 |
|
|
2020
Q2 | $100 | Hold |
28
| – | – | ﹤0.01% | 643 |
|
|
2020
Q1 | $106 | Hold |
28
| – | – | ﹤0.01% | 647 |
|
|
2019
Q4 | $98 | Buy |
+28
| New | +$98 | ﹤0.01% | 626 |
|